Please login to the form below

Not currently logged in
Email:
Password:

Dr Holger Adelmann joins DIA EMEA

Succeeds Dr Jytte Lynvig as senior vice president and managing director

Dr Holger AdelmannThe DIA (Drug Information Association) has appointed Dr Holger Adelmann as its new senior vice president and managing director for DIA Europe, Middle East and Africa (EMEA).

Dr Adelmann brings nearly 30 years of clinical pharmacology experience to the role at the Washington, DC-headquartered group.

He joined the industry in 1989 and has previously held leading positions at AstraZeneca, Bayer, Merk Serono and Tropon.

Most recently, Dr Adelmann served as the global head of Merck Serono's clinical pharmacology and clinical biomarker operations in Germany.

In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.

Barbara Lopez Kunz, DIA's global chief executive, said: “Holger's diverse background provides us with the leadership necessary to deliver that trusted, future-oriented knowledge and connect the global health care community to this rapidly evolving region.”

Dr Adlemann succeeds Dr Jytte Lynvig who retired from the post earlier this month.

22nd February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics